Joseph H. Cort

Person

Tucson, AZ, US

People

Patents Grantslast 30 patents

Information Patent Grant
N-substituted derivatives of 1-desaminovasopressin
- Patent number 4,829,051
- Issue date May 9, 1989
- Vega Laboratories, Inc.
- Joseph H. Cort
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method and feed for stimulating the growth of animals
- Patent number 4,355,024
- Issue date Oct 19, 1982
- Joseph H. Cort
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Grant
Vasopressin analogs
- Patent number 4,285,858
- Issue date Aug 25, 1981
- Mt. Sinai School of Medicine of the City University of N.Y.
- Joseph H. Cort
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Orally active MIF analogs with an effect on the central nervous system
- Patent number 4,278,595
- Issue date Jul 14, 1981
- Vega Laboratories, Inc.
- Joseph H. Cort
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for prophylaxis and/or treatment of sickle cell disease
- Patent number 4,263,283
- Issue date Apr 21, 1981
- Ferring Pharmaceuticals, Inc.
- Joseph H. Cort
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for prophylaxis and/or treatment of sickle cell disease
- Patent number 4,261,980
- Issue date Apr 14, 1981
- Vega Laboratories, Inc.
- Joseph H. Cort
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for producing high potency factor VIII
- Patent number 4,235,881
- Issue date Nov 25, 1980
- Joseph H. Cort
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for producing high potency factor VIII
- Patent number 4,221,780
- Issue date Sep 9, 1980
- Joseph H. Cort
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Joseph H. Cort

Person

Patents Grantslast 30 patents

N-substituted derivatives of 1-desaminovasopressin

Method and feed for stimulating the growth of animals

Vasopressin analogs

Orally active MIF analogs with an effect on the central nervous system

Method for prophylaxis and/or treatment of sickle cell disease

Method for prophylaxis and/or treatment of sickle cell disease

Method for producing high potency factor VIII

Method for producing high potency factor VIII